Farms.com Home   News

Hay Continues To Move West

Hay is continuing to be shipped to the Prairies through the Canadian Federation of Agriculture's Hay West Initiative.

"It's been going quite well from the perspective that supply and demand are both certainly very strong," said CFA President Mary Robinson. "We have producers in western Canada, who have been very pleased with the hay they've received. We've had a couple of hiccups as I think anyone would expect for something of this magnitude and we've got lots of hay in Ontario, Quebec, and the Atlantic provinces to move west. The challenge right now is securing funding to offset the transportation costs, because obviously the transportation costs are extremely high."

CFA is operating on a break-even basis under this initiative, with hay being purchased from Eastern and Central Canadian farmers and resold at cost to recipients.

"The big thing is making sure that we've got the money to get hay in the hands of the producers who need it. We're prioritizing people who have water for their animals and have breeding stock. Trying to respond to that as effectively as we can," added Robinson.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.